Aspects of Peptidomimetics - Peptide and Protein Design for Biopharmaceutical Applications - page 114

[141] D. Coy, L. H. Wang, N. Y. Jiang and R. Jensen, Short chain bombesin pseudopep-
tides with potent bombesin receptor antagonist activity in rat and guinea-pig
pancreatic acinar-cells, Eur.J.Pharmacol ., 190, 31-38 (1990).
[142] M. Hiramatsu, K. Inoue, A. Ambo, Y. Sasaki and T. Kameyama, Long-lasting
antinociceptive effects of a novel dynorphin analogue, Tyr- D -Ala-Phe-Leu-Arg c
(CH 2 NH) Arg-NH 2 , in mice, Brit.J.Pharmacol ., 132, 1948-1956 (2001).
[143] G. E. Feurle, H. E. Meyer and G. Hamscher, Metabolism and potency of xenin and
of its reduced hexapseudopeptide c fragment in the dog, Life Sci ., 74, 697-707
(2003).
[144] J. Martinez, J. P. Bali, M. Rodriguez, B. Castro, R. Magous, J. Laur and
M. F. Lignon, Synthesis and biological-activities of some pseudo-peptide analogues
of tetragastrin - the importance of the peptide backbone, J.Med.Chem ., 28,
1874-1879 (1985).
[145] S. Zacharia, W. J. Rossowski, N. Y. Jiang, P. Hrbas, A. Ertan and D. H. Coy, New
reduced peptide-bond substance-P agonists and antagonists - effects on smooth-
muscle contraction, Eur.J.Pharmacol ., 203, 353-357 (1991).
[146] N. G. J. Delaet, P. M. F. Verheyden, D. Tourwe´, G. VanBinst, P. Davis and
T. F. Burks, Morphiceptin and beta-casomorphin-5 analogues containing a reduced
peptide-bond - selective mu-receptor agonists and a novel mu antagonist, H-Tyr-
Pro-c(CH 2 -NH) Phe-Pro-Gly-OH, Biopolymers , 32, 957-969 (1992).
[147] A. Balasubramaniam, V. C. Dhawan, D. E. Mullins, W. T. Chance, S. Sheriff, M.
Guzzi, M. Prabhakaran and E. M. Parker, Highly selective and potent neuropeptide
Y (NPY) Y1 receptor antagonists based on [Pro(30), Tyr(32), Leu(34)]NPY
(28-36)-NH 2 (BW1911U90), J.Med.Chem ., 44, 1479-1482 (2001).
[148] G. Calo', R. Guerrini, R. Bigoni, A. Rizzi, C. Bianchi, D. Regoli and S. Salvadori,
Structure-activity study of the nociceptin(1-13)-NH 2 N-terminal tetrapeptide and
discovery of a nociceptin receptor antagonist, J.Med.Chem ., 41, 3360-3366
(1998).
[149] J. R. Wisner, B. G. Xue, D. H. Coy and I. G. Renner, ( D -Ala1, Leu9-c-CH 2 NH-
Leu10)Neuromedin-C antagonizes neuromedin C-stimulated amylase release by
acini isolated from the rat pancreas, Pancreas , 5, 408-414 (1990).
[150] Q. Y. Zhao, Q. Chen, D. J. Yang, Y. Feng, Y. Long, P. Wang and R. Wang,
Endomorphin 1[c] and endomorphin 2[c], endomorphins analogues containing a
reduced (CH 2 NH) amide bond between Tyr(1) and Pro(2), display partial agonist
potency but significant antinociception, Life Sci ., 77, 1155-1165 (2005).
[151] M. Szelke, B. Leckie, A. Hallett, D. M. Jones, J. Sueiras, B. Atrash and A. F. Lever,
Potent new inhibitors of human renin, Nature , 299, 555-557 (1982).
[152] K. Suguna, E. A. Padlan, C. W. Smith, W. D. Carlson and D. R. Davies, Binding of a
reduced peptide inhibitor to the aspartic proteinase from rhizopus-chinensis - impli-
cations for a mechanism of action, P.Natl.Acad.Sci.USA , 84, 7009-7013 (1987).
[153] D. Skrbec and D. Romeo, Inhibition of Candida albicans secreted aspartic protease
by a novel series of peptidomimetics, also active on the HIV-1 protease,

Biochem.Bioph.Res.Co ., 297, 1350-1353 (2002).
[154] J. S. Wai, D. L. Bamberger, T. E. Fisher, S. L. Graham, R. L. Smith, J. B. Gibbs,
S. D. Mosser, A. I. Oliff, D. L. Pompliano, E. Rands and N. E. Kohl, Synthesis and
biological activity of Ras Farnesyl Protein Transferase inhibitors. Tetrapeptide
analogues with amino methyl and carbon linkages, Bioorg.Med.Chem ., 2,

939-947 (1994).